QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
26 avr. 2024 08h30 HE
|
QHSLab, Inc.
WEST PALM BEACH, FL, April 26, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. ("the Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with...
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss
28 mars 2024 08h00 HE
|
QHSLab, Inc.
WEST PALM BEACH, FL, March 28, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare...
QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results
14 nov. 2023 08h30 HE
|
QHSLab, Inc.
25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit. ●In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from...
QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
24 mai 2022 08h00 HE
|
QHSLab, Inc.
WEST PALM BEACH, FL, May 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through...
QHSLab. Issues Update and Investor Presentation May 2022
09 mai 2022 08h30 HE
|
QHSLab, Inc.
Superior Business Model and Strategic Position Validated By Repeat Ordering Client Base and New Developments to Product Portfolio Addressable Market Opportunity Includes Over 250,000...
USA Equities Corp. Reports Fourth Quarter and Full Year 2021 Financial Results
05 avr. 2022 08h00 HE
|
USA Equities Corp
Fourth Quarter 2021 Revenue Up 265% ●Revenue Surpassed $1.4 million for the year ended 2021 Compared to $124,000 for 2020●Gross Margin of 52% in Q4 Increased 1,200 Basis Points Versus Q4 2020●Strong...
QHSLab Expands Digital Prescription Product Portfolio in 2022
16 févr. 2022 08h00 HE
|
USA Equities Corp
The company is introducing additional point-of-care digital healthcare and clinical decision-making tools into the market throughout the coming year.A major milestone includes the launch of the...
USA Equities Corp. Introduces AllergiQT™ – Quick Test, Further Expanding Market Presence
29 nov. 2021 08h00 HE
|
USA Equities Corp
FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary Care SettingsStrengthens USA Equities...
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand
19 oct. 2021 08h30 HE
|
USA Equities Corp
Strengthening Business Model and Expanding Product Portfolio in Large Addressable End MarketQ-Scale Represents a Compelling and Reimbursable Value Proposition for USAQ’s Physician ClientsFurther...
USA Equities Corp. Announces Strong Second Quarter 2021 Results
17 août 2021 08h30 HE
|
USA Equities Corp
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired AllergiEnd® Assets...